Cytek Biosciences Inc.
CTKB | NASDAQ
$5.28
-$0.02 (-0.38%)
At close: Sep 21, 2026, 4:00 PM ET
$5.48
+$0.20 (+3.79%)
Pre-market:
Sep 22, 2026, 7:42 AM ET
Market Data
Market Cap $681.87M
Enterprise Value $446.33M
Beta 1.19
Average Volume 1.21M
Shares Outstanding (Diluted) 129.46M
Shares Change YoY 1.99%
Institutional Ownership 66.10%
Exchange NASDAQ
ISIN US23285D1090
Price Performance
Price Change 1M 9.1%
Price Change 3M 29.7%
Price Change 6M 14.8%
Price Change YTD 7.3%
Price Change 1Y 36.8%
Price Change 3Y -17.2%
Price Change 5Y -78.1%
1M CAGR (ann.) 25.7%
1Y CAGR (ann.) 29.1%
5Y CAGR (ann.) -27.4%
All-Time CAGR -21.8%
Valuation
PE Ratio -8.52
Forward PE N/A
PEG Ratio 0.06
Forward PEG 0.32
PS Ratio 3.30
Forward PS 3.10
PB Ratio 2.12
P/FCF Ratio -40.15
P/Adj. FCF Ratio -15.78
P/OCF Ratio -105.60
EV/Sales 2.16
EV/EBIT -11.43
EV/EBITDA -14.81
EV/FCF -26.28
Earnings Yield -11.7%
FCF Yield -2.5%
Adj. FCF Yield -6.3%
Financial Health
Net Cash $252.33M
Total Debt $26.46M
Cash & Short-Term Investments $262M
Total Assets $446.93M
Current Ratio 4.48
Quick Ratio 3.86
Debt / Equity Ratio 0.08
Debt / EBITDA -0.88
Debt / FCF -1.56
OCF / Debt -0.33
Interest Coverage -25.34
Altman Z-Score 3.82
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 53.2%
Operating Profit Margin -21.6%
EBITDA Margin -13.1%
Net Profit Margin -39.0%
FCF Margin -8.2%
Adj. FCF Margin -20.9%
SBC / Revenue 10.3%
SBC Impact (per share) -154.4%
Returns
Return on Assets -18.0%
Return on Equity -23.5%
Return on Invested Capital -11.9%
Return on Capital Employed -12.3%
Return on Tangible Assets -19.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 5.6%
Revenue CAGR 5Y 13.4%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -91.4%
EPS CAGR 5Y -72.7%
EPS CAGR 10Y N/A
FCF CAGR 3Y -875.2%
FCF CAGR 5Y 19.9%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 5
EPS Growth Next 3Y 29.0%
Revenue Growth Next 3Y 7.8%
Earnings Date Nov 3, 2026
EPS Estimate (next Q) -$0.07
EPS Growth Est (next Q) 600.0%
Revenue Est (next Q) $52.95M
Revenue Growth Est (next Q) 1.3%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $4.88
Price Target Upside -7.6%
Cash Flow
Operating Cash Flow $-8.77M
Free Cash Flow $-16.98M
Adj. Free Cash Flow $-43.21M
FCF Per Share -$0.09
OCF Per Share -$0.05
OCF/S Ratio -2.9%
Income Statement
Revenue $206.71M
Gross Profit $110.03M
Operating Income $-44.65M
EBITDA $-30.14M
Net Income $-80.58M
EPS (Diluted) -$0.62
Revenue / Employee $303.09K
Profit / Employee $-118.15K
Employees 682
Add to Watchlist
Select watchlists to add or remove CTKB